MTNB
Price
$0.61
Change
-$0.01 (-1.61%)
Updated
May 2 closing price
Capitalization
3.1M
VKTX
Price
$29.36
Change
+$0.75 (+2.62%)
Updated
May 2 closing price
Capitalization
3.3B
81 days until earnings call
Ad is loading...

MTNB vs VKTX

Header iconMTNB vs VKTX Comparison
Open Charts MTNB vs VKTXBanner chart's image
Matinas Biopharma Holdings
Price$0.61
Change-$0.01 (-1.61%)
Volume$43.82K
Capitalization3.1M
Viking Therapeutics
Price$29.36
Change+$0.75 (+2.62%)
Volume$4.45M
Capitalization3.3B
MTNB vs VKTX Comparison Chart
Loading...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTNB vs. VKTX commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a StrongBuy and VKTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (MTNB: $0.61 vs. VKTX: $29.36)
Brand notoriety: MTNB and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 118% vs. VKTX: 100%
Market capitalization -- MTNB: $3.1M vs. VKTX: $3.3B
MTNB [@Biotechnology] is valued at $3.1M. VKTX’s [@Biotechnology] market capitalization is $3.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than MTNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTNB’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • MTNB’s TA Score: 5 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both MTNB and VKTX are a good buy in the short-term.

Price Growth

MTNB (@Biotechnology) experienced а -8.96% price change this week, while VKTX (@Biotechnology) price change was +17.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

MTNB is expected to report earnings on Apr 15, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.3B) has a higher market cap than MTNB($3.1M). MTNB YTD gains are higher at: 19.608 vs. VKTX (-27.038). MTNB has higher annual earnings (EBITDA): -21.05M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. MTNB (10.8M). VKTX has less debt than MTNB: VKTX (1M) vs MTNB (3.07M). MTNB (0) and VKTX (0) have equivalent revenues.
MTNBVKTXMTNB / VKTX
Capitalization3.1M3.3B0%
EBITDA-21.05M-171.93M12%
Gain YTD19.608-27.038-73%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.8M852M1%
Total Debt3.07M1M307%
FUNDAMENTALS RATINGS
MTNB vs VKTX: Fundamental Ratings
MTNB
VKTX
OUTLOOK RATING
1..100
1624
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9534
PRICE GROWTH RATING
1..100
5963
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (25) in the Biotechnology industry is in the same range as VKTX (47). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as MTNB (100). This means that VKTX’s stock grew similarly to MTNB’s over the last 12 months.

VKTX's SMR Rating (34) in the Biotechnology industry is somewhat better than the same rating for MTNB (95). This means that VKTX’s stock grew somewhat faster than MTNB’s over the last 12 months.

MTNB's Price Growth Rating (59) in the Biotechnology industry is in the same range as VKTX (63). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VKTX (100). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTNBVKTX
RSI
ODDS (%)
Bearish Trend 9 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPR72.762.27
+3.22%
Tapestry
ITP0.260.01
+3.03%
IT Tech Packaging
UFI5.140.10
+1.98%
UNIFI
GMRE7.810.11
+1.43%
Global Medical REIT
MTX53.010.32
+0.61%
Minerals Technologies

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with EQ. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-1.61%
EQ - MTNB
37%
Loosely correlated
+2.44%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
+3.21%
AXON - MTNB
34%
Loosely correlated
+1.14%
VKTX - MTNB
32%
Poorly correlated
+2.60%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with MREO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+2.60%
MREO - VKTX
44%
Loosely correlated
+2.69%
KRYS - VKTX
44%
Loosely correlated
+0.28%
ALT - VKTX
43%
Loosely correlated
+11.61%
CRNX - VKTX
43%
Loosely correlated
+0.72%
ROIV - VKTX
43%
Loosely correlated
-0.86%
More